A global hub of interdisciplinary innovation for the elimination of poverty-driven corneal blindness in poor communities worldwide.

A global hub of interdisciplinary innovation for the elimination of poverty-driven corneal blindness in poor communities worldwide.

A $2m program of collaborative research with Harvard Medical School in Boston to achieve new breakthroughs in corneal disease.

A $2m program of collaborative research with Harvard Medical School in Boston to achieve new breakthroughs in corneal disease.

Leading the scientific development a proprietary biosynthetic to reduce reliance on expensive surgery to cure corneal blindness.

Leading the scientific development a proprietary biosynthetic to reduce reliance on expensive surgery to cure corneal blindness.

Funding the purchase of the world's first clinically-approved 3D-printed bionic arms for young people in the UK with limb difference.

Funding the purchase of the world's first clinically-approved 3D-printed bionic arms for young people in the UK with limb difference.

Supporting targeted projects within underserved communities where direct interventions can have a sustained and positive impact.

Supporting targeted projects within underserved communities where direct interventions can have a sustained and positive impact.

"I rebuilt myself into a big success, and I’m determined to use that success to help rebuild others too. I am extremely proud of the impact that I have been able to make. Of course no matter what you do there will always be people who want to bring you down. But they only want to see you down because it makes them feel better about themselves. Don’t give them that satisfaction. Keep building yourself. Keep giving back. And keep helping others." Mr. Tej Kohli

Tej Kohli Cornea Institute

The Tej Kohli Cornea Institute is an eminent institution for R&D, preventative medicine and corneal transplants. Between January 2016 and November 2019 it welcomed 223,404 outpatients and carried out 43,255 surgical procedures, largely for free. The Institute also delivers prevention, treatment and cures for corneal blindness within some of the world’s poorest communities in remote and rural areas.

Tej Kohli Cornea Program

The Tej Kohli Cornea Program at Mass. Eye & Ear, a teaching hospital of Harvard Medical School, is a $2m program to accelerate innovative and collaborative research to achieve unprecedented breakthroughs in corneal disease. The Tej Kohli Cornea Program includes cutting-edge molecular technology for the rapid diagnosis of corneal infection, and also GelCORE, an adhesive biomaterial for replacing corneal tissue.

Tej Kohli Applied Research

Supported by an advisory board that includes the most eminent ophthalmologists from around the world, the Tej Kohli Research Centre is engaged in the pursuit of an accessible, affordable and scalable solution for eliminating corneal blindness that does not rely on surgery or donated cornea, through the development of a proprietary synthetic biotech that could be relevant to one-third of those waiting for corneal transplants worldwide.

Tej Kohli Future Bionics

The Tej Kohli Future Bionics program highlights how technology can substantially improve the lives and confidence of younger people living with disabilities. The program epitomises the Tej Kohli Foundation’s focus on helping young people who are living with disability by making a direct and meaningful intervention into their lives using technology. The program funds the purchase and fitting of the bionic multi-grip myoelectric controlled prosthetic ‘Hero Arm’ for young people in the United Kingdom who are living with limb difference.

Tej Kohli Impact Initiatives

The Tej Kohli Foundation supports projects in underserved communities where direct interventions can have a sustained and positive impact on individual lives. ‘Impact Initiatives’ include financial support for disabled children in Costa Rica, feeding over 1,000 schoolchildren in poor communities every day at after-school clubs, and producing a ‘social impact entertainment’ film to highlight the neglect of young people in India who are living with XP, a rare genetic disease.